The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

The rise of GLP-1s have made treating obesity one of the largest market opportunities in history. It also has reinforced a ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.